Abivax Reports Share Capital and Voting Rights

TipRanksMay 30 03:13

Abivax Initiated at Buy by BTIG

Abivax Initiated at Buy by BTIG

Dow JonesMay 20 06:46

Abivax (ABVX.US) was first covered by BTIG and given a buy rating, with a target price of $43.00.

Abivax (ABVX.US) was first covered by BTIG and given a buy rating, with a target price of $43.00.

Zhitong FinanceMay 20 06:40

BTIG Initiates Coverage On Abivax With Buy Rating, Announces Price Target of $43

BTIG analyst Julian Harrison initiates coverage on Abivax (NASDAQ:ABVX) with a Buy rating and announces Price Target of $43.

BenzingaMay 20 06:36

Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Abivax SA Sponsored ADR (ABVX)

TipRanksMay 20 03:50

Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Preclinical Colon Cancer Model at Digestive Disease Week 2024

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 PARIS, France, May 8, 2024, 8:30 a.m. CEST – Abivax SA

GlobeNewswireMay 8 01:30